Costa, Luciano J. http://orcid.org/0000-0001-5362-2469
Derman, Benjamin A. http://orcid.org/0000-0002-4070-1819
Bal, Susan
Sidana, Surbhi http://orcid.org/0000-0003-3288-7614
Chhabra, Saurabh
Silbermann, Rebecca
Ye, Jing C.
Cook, Gordon http://orcid.org/0000-0003-1717-0412
Cornell, Robert F.
Holstein, Sarah A. http://orcid.org/0000-0002-9342-5635
Shi, Qian
Omel, James
Callander, Natalie S.
Chng, Wee Joo
Hungria, Vania
Maiolino, Angelo http://orcid.org/0000-0003-0140-9548
Stadtmauer, Edward
Giralt, Sergio http://orcid.org/0000-0003-1944-5053
Pasquini, Marcelo
Jakubowiak, Andrzej J.
Morgan, Gareth J.
Krishnan, Amrita
Jackson, Graham H.
Mohty, Mohamad
Mateos, Maria Victoria http://orcid.org/0000-0003-2390-1218
Dimopoulos, Meletious A.
Facon, Thierry
Spencer, Andrew
Miguel, Jesus San
Hari, Parameswaran
Usmani, Saad Z.
Manier, Salomon
McCarthy, Phillip
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Gay, Francesca
Paiva, Bruno http://orcid.org/0000-0003-1977-3815
Article History
Received: 19 June 2020
Revised: 27 July 2020
Accepted: 29 July 2020
First Online: 11 August 2020
Compliance with ethical standards
:
: LC: Honoraria (Amgen, Bristol-Myers-Squibb, AbbVie), Research Funding (Amgen, Bristol-Myers-Squibb, Janssen); RS: Honoraria (Janssen); VH: Honoraria (Janssen, AbbVie, Amgen, Bristol-Myers-Squibb, Celgene, Takeda); W-JC: Honoraria (Takeda); ES: Honoraria (Celgene, Takeda, Novartis, Teva, Janssen, Amgen, Sanofi); SG: Honoraria (Celgene, Takeda, Amgen, Jazz Pharmaceuticals, Sanofi, Sanofi, Janssen), Research Funding (Celgene, Takeda, Miltenyi Biotec, Johnson & Johnson, Amgen); AJJ: Honoraria (Amgen, Bristol-Myers-Squibb, Janssen, Takeda, Skyline DX), Consultancy (Abbvie); GJM: Honoraria (Celgene, Bristol-Myers-Squibb, Novartis, Roche, Genentech, Takeda, Amgen, Karyopharm, Sanofi, GlaxoSmithKline, Janssen); AK: Ownership Interest (Celgene, Kite Pharma), Honoraria (Celgene, Onyx, Janssen, Takeda, Kite Pharma, Seattle Genetics), Research Funding (Celgene, Takeda); GHJ: Honoraria (Roche, Amgen, Janssen); MM: Honoraria (Janssen, Sanofi, Jazz Pharmaceuticals, Celgene, Bristol-Myers Squibb, Takeda, Amgen, Roche); MM: Honoraria (Janssen, Sanofi, Jazz Pharmaceuticals, Celgene, Bristol-Myers Squibb, Takeda, Amgen) Research support (Roche); MVV: Honoraria (Janssen, Celgene, Amgen, Takeda, AbbvVie, GlaxoSmithKline, Adaptive, Edo-Mundipharma, PharmaMar); MAD: Honoraria (Amgen, Janssen, Takeda, Celgene, Bristol-Myers Squibb); TF: Honoraria (Celgene, Janssen, Takeda, Amgen, Sanofi, Karyopharm, Oncopeptides, Roche); AS: Honoraria (Takeda, Celgene, Janssen, Amgen), Research funding (Takeda, Celgene, Janssen, GlaxoSmithKline); JSM: Honoraria (Amgen, Bristol-Myers Squibb, Celgene, Janssen, MSD, Novartis, Takeda, Sanofi, Roche); PH: Honoraria (Takeda, Prothena, Pfizer), Research funding (Takeda); SU: Honoraria (Bristol-Myers-Squibb, Amgen, Takeda, Sanofi, Janssen), Research funding (Onyx, Janssen, Sanofi, Array BioPharma, Pharmacyclics, Takeda, Celgene, Bristol-Myers Squibb); PM: Honoraria (Celgene, Karyopharm Therapeutics, Bristol-Myers Squibb, Sanofi, Janssen, The Binding Site), Research support (Celgene); SK: Honoraria (AbbVie, Celgene, Kite Pharma). FG: Honoraria (Takeda, Amgen, Celgene, Janssen, Bristol-Myers-Squibb, Seattle Genetics, Roche). BP: Honoraria (Amgen, Bristol-Myers Squibb, Celgene, Janssen-Cilag, Takeda, Sanofi), Research funding (Celgene, Janssen-Cilag, Sanofi, Takeda).